Comparison of two topical formulations containing clindamycin and clotrimazole in patients with vaginal infections
- Conditions
- Health Condition 1: null- Non-pregnant women above 18 years with clinical diagnosis of vaginitis of infective origin, willing to participate in the study and abide by the study rules
- Registration Number
- CTRI/2011/04/001698
- Lead Sponsor
- Bharti Daswani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Women with symptoms of vaginal discharge and/or odor and a clinical diagnosis of vaginitis of infective origin [based on symptoms and signs on per speculum examination]
Age at least 18 years
Capable of giving written informed consent
Agree to no intercourse for 8 days from the day of start of treatment
Agree not to douche or use any intravaginal products during the study period (including tampons, medications and devices)
Post-menopausal women
Menstruating at diagnosis
Pregnancy
Any antifungal or antibiotic use 14 days prior to enrolment
Use of oral or intravaginal antibiotics within the past 2 weeks
Immunosuppressive drug within 4 months
Presence of vaginal / vulval ulcer
Presence of any other vulval, vaginal or medical condition, including cervical neoplasia/ treatment that might confound treatment response
Inability to keep return appointments
History of hypersensitivity to clotrimazole, clindamycin or lincomycin
History of regional enteritis, ulcerative colitis or ?antibiotic associated? colitis
Significant disease or acute illness that in the Investigators assessment could complicate the evaluation
Intrauterine Device
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method